COVID-19预后评分的外部验证:大巴黎大学医院多中心队列研究
该研究为回顾性多中心队列,纳入2020年1月至2021年4月大巴黎大学医院住院的14343例成人COVID-19患者,旨在外部验证现有预后评分。通过COVID-19 Evidence Alerts检索高质量预后评分,共32个评分符合纳入标准。主要结果为:19个评分对原始结局的AUC显著低于既往验证研究;25个评分预测院内死亡的效能优于复合结局(死亡或ICU转运);7个评分预测院内死亡的AUC>0.75;2个评分预测复合结局的AUC>0.70。4C Mortality Score和ABCS在初始验证队列和本队列、各疫情波次及年轻和老年患者中表现一致。
要点
- 在14343例住院COVID-19患者中,2583例(18%)死亡,5067例(35%)死亡或转入ICU。
- 共验证32个预后评分,其中19个对原始结局的AUC显著低于既往验证研究。
- 7个评分预测院内死亡的AUC>0.75,2个评分预测复合结局(死亡或ICU转运)的AUC>0.70。
- 4C Mortality Score和ABCS在初始验证队列与本队列、第一波与后续波次、年轻与老年患者中表现稳定。
- 多数评分预测院内死亡的效能优于预测死亡或ICU转运的复合结局(25/32)。
适用人群与场景
- 2020年1月至2021年4月大巴黎大学医院住院的成人COVID-19患者,共14343例连续病例。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:回顾性多中心队列研究;样本量14343例连续住院成人COVID-19患者;中心数:大巴黎大学医院(具体中心数原文未提及)。
- 干预与对照:无干预,外部验证32个预后评分(通过COVID-19 Evidence Alerts检索高质量预后评分)。
- 主要终点结果:19个评分对原始结局的AUC显著低于既往验证研究;7个评分预测院内死亡AUC>0.75;2个评分预测复合结局(死亡或ICU转运)AUC>0.70。
- 关键次要终点:2583例(18%)死亡,5067例(35%)死亡或转入ICU;25个评分预测院内死亡的效能优于复合结局。
- 不良事件:原文未提及。
证据类型、等级与局限
- 证据类型:回顾性多中心队列研究(外部验证研究)。
- 证据等级或推荐强度:原文未提及。
- 局限:回顾性设计;原文未提及其他局限。
对床旁实践的改变
- 在住院COVID-19成人患者中,可考虑使用4C Mortality Score或ABCS预测院内死亡,因其在本队列和初始验证队列、各疫情波次及不同年龄组中表现稳定。
- 多数预后评分预测院内死亡的效能优于预测死亡或ICU转运的复合结局,临床用于死亡风险评估时需注意结局定义差异。
- 部分评分在本队列中对原始结局的AUC显著低于既往验证研究,直接套用可能高估其效能。
- 原文未提及适用与不适用人群的明确界定,使用评分时需结合具体临床场景。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: The Coronavirus disease 2019 (COVID-19) has led to an unparalleled influx of patients. Prognostic scores could help optimizing healthcare delivery, but most of them have not been comprehensively validated. We aim to externally validate existing prognostic scores for COVID-19.
METHODS: We used "COVID-19 Evidence Alerts" (McMaster University) to retrieve high-quality prognostic scores predicting death or intensive care unit (ICU) transfer from routinely collected data. We studied their accuracy in a retrospective multicenter cohort of adult patients hospitalized for COVID-19 from January 2020 to April 2021 in the Greater Paris University Hospitals. Areas under the receiver operating characteristic curves (AUC) were computed for the prediction of the original outcome, 30-day in-hospital mortality and the composite of 30-day in-hospital mortality or ICU transfer.
RESULTS: We included 14,343 consecutive patients, 2583 (18%) died and 5067 (35%) died or were transferred to the ICU. We examined 274 studies and found 32 scores meeting the inclusion criteria: 19 had a significantly lower AUC in our cohort than in previously published validation studies for the original outcome; 25 performed better to predict in-hospital mortality than the composite of in-hospital mortality or ICU transfer; 7 had an AUC > 0.75 to predict in-hospital mortality; 2 had an AUC > 0.70 to predict the composite outcome.
CONCLUSION: Seven prognostic scores were fairly accurate to predict death in hospitalized COVID-19 patients. The 4C Mortality Score and the ABCS stand out because they performed as well in our cohort and their initial validation cohort, during the first epidemic wave and subsequent waves, and in younger and older patients.
参考来源
- Lombardi Y, Azoyan L, Szychowiak P, et al. External validation of prognostic scores for COVID-19: a multicenter cohort study of patients hospitalized in Greater Paris University Hospitals. Intensive Care Med. 2021. PMID: 34585270. doi:10.1007/s00134-021-06524-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。